Vat Photopolymerization-Fabricated Theranostic Hydrogels for Smart Wound Management

Despite the demand for personalized wound care, integrating diagnostics and therapeutics into a unified platform remains a significant challenge. To address this, we developed a 3D-printed theranostic hydrogel using vat photopolymerization, enabling precise, multifunctional wound management. The hydrogel matrix, composed of poly(acrylamide-co-hydroxyethyl acrylate) and carboxymethyl cellulose, was chemically crosslinked with poly(ethylene glycol) diacrylate. Bromocresol purple was integrated into the photosensitive resin to enhance printing fidelity and serve as a diagnostic indicator, providing a distinct colorimetric shift upon skin infection. For controlled drug delivery, graphene oxide (GO) and levofloxacin were incorporated into the system. The 3D-printed hydrogel demonstrated superior swelling capacity (>600%), ideal for absorbing wound exudate. A semi-quantitative linear colorimetric response was observed across varying pH levels, allowing for clear differentiation between healthy healing skin (pH 4.0-6.0) and infected conditions (pH 7.0 and above). Furthermore, the hydrogel exhibited infection-stimulated therapy, with a cumulative levofloxacin release of 92.63% at pH 8, significantly higher than in acidic conditions. Moreover, the incorporation of GO further optimized the delivery profile by tuning absorption and release rates. Synergizing real-time monitoring and on-demand therapeutic action, this 3D-printed system offers a scalable, robust solution for future-ready, personalized wound management.